Skip to content
Disclosery

MRA Advisory Group: LITE position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of MRA Advisory Group on LITE, newest first. How the timeline and the estimate are built.

MRA Advisory Group held 2,296 LITE shares at 2026-09-30 per its 13F-HR filed 2026-10-07.

the latest 13F is the newest step

  1. period ended2026-09-30
    13F 2,296 shares
    Change vs previous 13F +264 shares

    0.84% of the 13F portfolio, value $2,230,216.

    13F-HR 0001841816-26-000007 filed by MRA Advisory Group
    Accepted , ingested

  2. period ended2026-06-30
    13F 2,032 shares
    Change vs previous 13F -378 shares

    0.63% of the 13F portfolio, value $1,743,990.

    13F-HR 0001841816-26-000003 filed by MRA Advisory Group
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  3. period ended2026-03-31
    13F 2,410 shares
    Change vs previous 13F -244 shares

    0.69% of the 13F portfolio, value $1,693,992.

    13F-HR 0001841816-26-000002 filed by MRA Advisory Group
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  4. period ended2025-12-31
    13F 2,654 shares
    Change vs previous 13F -2,204 shares

    0.41% of the 13F portfolio, value $978,087.

    13F-HR 0001841816-26-000001 filed by MRA Advisory Group
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  5. period ended2025-09-30
    13F 4,858 shares
    Change vs previous 13F -1,282 shares

    0.34% of the 13F portfolio, value $790,475.

    13F-HR 0001841816-25-000005 filed by MRA Advisory Group
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  6. period ended2025-06-30
    13F 6,140 shares
    Change vs previous 13F not available

    0.27% of the 13F portfolio, value $583,624.

    13F-HR 0001841816-25-000003 filed by MRA Advisory Group
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).